Common Herpes Injectable Recalled for Clotting, Stroke Risk
Posted on Monday, March 29th, 2021
Four lots of acyclovir sodium injection produced by Zydus Pharmaceuticals (USA) Inc. have been voluntarily recalled after the company received notification from several hospitals and other administrators that the product had crystallized inside 50 mg/mL, 10 mL and 20 mL vials.
In the event that crystalized acyclovir sodium injection were administered to a patient, it could cause life-threatening adverse consequences. Injection site inflammation, damage to blood vessels, clotting, stroke, heart attack, decreased liver or kidney function, and/or death are possible. No adverse events have been reported prior to this recall.
Acyclovir sodium injection 50 mg/mL is used to treat herpes simplex and shingles infections in people with compromised immune systems. It is also used to treat herpes simplex encephalitis, as well as neonatal herpes simplex virus infections.
Recalled acyclovir sodium injection 50 mg/mL was distributed nationwide to Cardinal Health, Amerisourcebergen Drug Corporation, and Morris & Dickson Company LLC hospital networks.
If you or someone you love was harmed by this or any other defective drug or medical device, contact the personal injury attorneys at OnderLaw at 314-963-9000. Our dangerous drug lawyers are not afraid to take on big pharma. Call today for a free, no-obligation consultation.